Elanco Animal Health Incorporated Proceeds from Issuance of Senior Long-term Debt
Elanco Animal Health Incorporated (ELAN) reported Proceeds from Issuance of Senior Long-term Debt of $2.11 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt · last filed 2026-02-24
- Elanco Animal Health Incorporated proceeds from issuance of senior long-term debt for the quarter ending 2025-12-31 was $2.11B.
- Elanco Animal Health Incorporated proceeds from issuance of senior long-term debt for the quarter ending 2024-12-31 was $0.00.
- Elanco Animal Health Incorporated proceeds from issuance of senior long-term debt for the quarter ending 2023-12-31 was $0.00.
- Elanco Animal Health Incorporated proceeds from issuance of senior long-term debt for the quarter ending 2023-09-30 was $0.00.
- Elanco Animal Health Incorporated proceeds from issuance of senior long-term debt for fiscal 2025 was $2.11B, a 501.71% increase from fiscal 2024.
- Elanco Animal Health Incorporated proceeds from issuance of senior long-term debt for fiscal 2024 was $350.00M.
- Elanco Animal Health Incorporated proceeds from issuance of senior long-term debt for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Elanco Animal Health Incorporated proceeds from issuance of senior long-term debt for fiscal 2022 was $425.00M, a 15.00% decline from fiscal 2021.
| Period end | Proceeds from Issuance of Senior Long-term Debt 3 month | Proceeds from Issuance of Senior Long-term Debt 3 month as first filed | Proceeds from Issuance of Senior Long-term Debt 6 month | Proceeds from Issuance of Senior Long-term Debt 6 month as first filed | Proceeds from Issuance of Senior Long-term Debt 9 month | Proceeds from Issuance of Senior Long-term Debt 9 month as first filed | Proceeds from Issuance of Senior Long-term Debt 12 month | Proceeds from Issuance of Senior Long-term Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $2.11B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.11B 10-K · filed 2026-02-24 | ||||||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-05 | |||||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $350.00M 10-K · filed 2026-02-24 | ||||||
| 2024-09-30 | $350.00M 10-Q · filed 2025-11-05 | |||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 10-K · filed 2026-02-24 | |||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | ||||||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-07 | |||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $425.00M 10-K · filed 2025-02-25 | |||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $425.00M 10-Q · filed 2023-11-07 | ||||||
| 2022-06-30 | $425.00M 10-Q · filed 2023-08-07 | |||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $500.00M derived: sum of 2 quarters · filed 2023-03-01 | $500.00M derived: sum of 3 quarters · filed 2023-03-01 | $500.00M 10-K · filed 2023-03-01 | ||||
| 2021-09-30 | $500.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $500.00M derived: sum of 2 quarters · filed 2022-11-08 | $500.00M 10-Q · filed 2022-11-08 | $750.00M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | $250.00M derived: sum of 3 quarters · filed 2023-03-01 | $4.72B derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-07 | $250.00M derived: sum of 2 quarters · filed 2023-03-01 | $4.72B derived: sum of 3 quarters · filed 2023-03-01 | $4.72B derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $250.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $4.72B derived: sum of 2 quarters · filed 2023-03-01 | $4.72B derived: sum of 3 quarters · filed 2023-03-01 | $4.80B 10-K · filed 2023-03-01 | $4.80B 10-K · filed 2021-03-01 | |||
| 2020-09-30 | $4.47B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $4.47B derived: sum of 2 quarters · filed 2021-11-05 | $4.55B 10-Q · filed 2021-11-05 | $4.55B 10-Q · filed 2020-11-06 | $4.55B derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $79.00M 10-Q · filed 2021-08-09 | $79.20M 10-Q · filed 2020-07-30 | $79.00M derived: sum of 3 quarters · filed 2022-02-28 | $79.00M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $79.00M 10-Q · filed 2021-05-07 | $79.20M 10-Q · filed 2020-05-07 | $79.00M derived: sum of 2 quarters · filed 2022-02-28 | $79.00M derived: sum of 3 quarters · filed 2022-02-28 | $79.00M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $0.00 derived: sum of 2 quarters · filed 2020-11-06 | $0.00 10-Q · filed 2020-11-06 | $22.30M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $0.00 10-Q · filed 2020-07-30 | $22.30M derived: sum of 3 quarters · filed 2021-03-01 | |||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | $22.30M derived: sum of 2 quarters · filed 2021-03-01 | ||||||
| 2018-12-31 | $22.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $2.50B 10-K · filed 2021-03-01 | ||||||
| 2018-09-30 | $2.48B 10-Q · filed 2019-11-08 | |||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $0.00 10-K · filed 2020-02-28 | ||||||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-08 | |||||||
| 2016-12-31 | $0.00 10-K · filed 2019-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |